Grants per year
- 75 - 85 out of 85 results
Search results
-
Finished
-
Prot# CCOX189A2360E1: 39-Wk, Opn-Lbl, Ext'n to CCOX189A2360, a 13-Wk, Mlticntr, Rndmzd, Dbl-Bld, Dbl-Dummy, Plcbo-Cntrld, Prl'l-Trial of 2 Different Dose Regimens of Lumiracoxib(100mg od & 200mg od Initial Dose for 2 wks Flw'd by 100mg od) in Pt's w/ Prim
Novartis Pharmaceuticals Corporation
1/1/04 → 11/27/06
Project: Research project
-
Prot# SP-NON-0010: Phase II Study on Analgesic Efficacy, Safety & Tolerability of AR-P900758XX: A 6 Week, Rndmzd, Dbl-Bld, Placebo-Controlled, Dose-Finding, Mltctr Study Comparing AR-P900758XX w/ Vioxx® & w/ Naproxen in Subjects w/ Osteoarthritis of Knee
Rheumatology Research International (RRI), AstraZeneca Pharmaceuticals LP
3/11/02 → 5/16/07
Project: Research project
-
Prot# CZOL446H2301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
PPD Development, Novartis Pharmaceuticals Corporation
1/11/02 → 8/1/06
Project: Research project